Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis

Cancer Immunology Research
Kiyomi ShitaokaAtsushi Muraguchi

Abstract

T-cell receptor (TCR) gene therapy is a promising next-generation antitumor treatment. We previously developed a single-T-cell analysis protocol that allows the rapid capture of paired TCRα and β cDNAs. Here, we applied the protocol to analyze the TCR repertoire of tumor-infiltrating lymphocytes (TIL) of various cancer patients. We found clonally expanded populations of T cells that expressed the same clonotypic TCR in 50% to 70% of CD137+CD8+ TILs, indicating that they responded to certain antigens in the tumor environment. To assess the tumor reactivity of the TCRs derived from those clonally expanded TILs in detail, we then analyzed the CD137+CD8+ TILs from the tumor of B16F10 melanoma cells in six C57BL/6 mice and analyzed their TCR repertoire. We also found clonally expanded T cells in 60% to 90% of CD137+CD8+ TILs. When the tumor reactivity of dominant clonotypic TCRs in each mouse was analyzed, 9 of 13 TCRs induced the secretion of IFNγ in response to, and showed killing of, B16F10 cells in vitro, and 2 of them showed strong antitumor activity in vivo Concerning their antigen specificity, 7 of them reacted to p15E peptide of endogenous murine leukemia virus-derived envelope glycoprotein 70, and the rest reacted to tumor-...Continue Reading

References

Jan 14, 1994·Cell·K A HogquistF R Carbone
Feb 3, 1997·The Journal of Experimental Medicine·M B BloomJ C Yang
Jun 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Felix J BakerMark M Davis
Mar 3, 2004·European Journal of Immunology·Wojciech Dawicki, Tania H Watts
Aug 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sabine SeitzKlaus Dornmair
Sep 2, 2006·Science·Richard A MorganSteven A Rosenberg
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laura A JohnsonSteven A Rosenberg
Jun 6, 2007·The Journal of Clinical Investigation·Carl H June
Jun 23, 2009·Genome Research·J Douglas FreemanRobert A Holt
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Chunlin WangJian Han
Jul 28, 2010·The Journal of Experimental Medicine·Elizabeth D ThompsonVictor H Engelhard
Dec 8, 2010·The Journal of Clinical Investigation·Pradyot DashPaul G Thomas
Jun 1, 2012·PloS One·Song-Min KimJoerg C Prinz
May 23, 2013·European Journal of Immunology·Maria A TurchaninovaDmitriy M Chudakov
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qunrui YeDaniel J Powell
Oct 15, 2013·Nature Medicine·Carsten LinnemannTon N M Schumacher
Jan 25, 2014·Nature Reviews. Cancer·Pierre G CoulieThierry Boon
Mar 29, 2014·The Journal of Clinical Investigation·Alena GrosSteven A Rosenberg
Jun 24, 2014·Nature Biotechnology·Arnold HanMark M Davis
Jul 18, 2015·Journal of Clinical Pharmacology·Lucy LeeSrikumar Sahasranaman
May 8, 2016·Biochemical and Biophysical Research Communications·Hiroshi HamanaAtsushi Muraguchi
Nov 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria ParkhurstSteven A Rosenberg
Mar 7, 2017·Nature Medicine·Maria J L KrachtBart O Roep
May 20, 2017·Cancer Research·Sarita M Fernandez-PomaSandra Hervas-Stubbs

❮ Previous
Next ❯

Citations

May 29, 2020·Journal of Experimental & Clinical Cancer Research : CR·Marco RussanoDaniele Santini
Oct 28, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jay FriedmanClint Allen
Feb 5, 2021·Cancer Immunology, Immunotherapy : CII·Min YangZong Sheng Guo
Nov 24, 2020·OncoTargets and Therapy·Xianzhe YuJianguo Li
Mar 7, 2021·Cancer Immunology Research·Hiroyasu AokiKouji Matsushima
Jun 8, 2021·Acta Pharmaceutica Sinica. B·Hassan DanaThomas J Webster
Aug 17, 2021·Frontiers in Immunology·Marie-Pierre PiccinniJulia Szekeres-Bartho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.